OB/GYN Annual Subject Index 2003

[ Subject | Author ]

Alternative medicine
Heat therapy: the next hot topic. Mar:30-39
Prenatal yoga: what you need to know. Feb:66-70
Treatment of obesity in the female patient: the role of laparoscopic adjustable gastric banding. Aug:27-33

back to top

Autoimmune disorders
Asthma in women: the hormonal link. Sep:34-41
Contraception in the lupus patient. Apr:51-52,61
Coping with systemic lupus erythematosus. Jun:38-40
HIV… the insidious disease. Sep:10
Pregnancy in the lupus patient. Apr:12-15
Biologic agents in the treatment of rheumatoid arthritis. Dec:27-31
Systemic lupus erythematosus: pathogenesis, diagnosis, and treatment. Feb:25-31

back to top

Bladder disorders
Comparator trials. Jun(CME suppl):9-14
Diagnostic evaluation of chronic pelvic pain of bladder origin. Jul(CME suppl):1-7
The evaluation and treatment of interstitial cystitis. Jun(CME suppl):19-26
Framework for understanding bladder health conditions [algorithm]. Jun(CME suppl):15
Framework for understanding overactive bladder, interstitial cystitis, urinary tract infection. Jun(CME suppl):5-8
Incidence, prevalence, and quality of life. Jun(CME suppl):3-4
Potassium sensitivity test. Jun(CME suppl):27-30

back to top

Bone densitometry
Images in women’s health. Feb:71-72

back to top

Cancer
A new look at progestogens. Oct(suppl):7-9
Clinical data on stool-based colorectal cancer screening test. Nov(CME suppl):6-8
Computerized analysis of breast images. Oct:45-49
The critical role of the primary care physician, ob/gyn, and the nurse practitioner in colorectal cancer screening. Nov(CME suppl):1-2
Establishing a colorectal cancer screening program. Nov(CME suppl):9-12
Implications of the Women’s Health Initiative – introduction. Oct(suppl):1-2
The importance of colorectal cancer screening. Nov(CME suppl):3-6
The importance of screening: the case for colorectal cancer. Oct:50-53
Managing the patient amid ongoing confusion. Oct(suppl):13-15
Overview and implications of the Women’s Health Initiative. Jan(CME suppl):4-7
Proteomic patterns: a potential test for early diagnosis of ovarian cancer. Dec:42,45-48,51-52
Results and implications of the Women’s Health Initiative trial of estrogen plus progestin. Oct(suppl):3-6
Using available data to select a hormone therapy. Oct(suppl):10-12

back to top

Cardiovascular disorders
A new look at progestogens. Oct(suppl):7-9
Hormone replacement therapy to prevent cardiovascular disease. Jun(suppl):15-20
Implications of the Women’s Health Initiative – introduction. Oct(suppl):1-2
Managing the patient amid ongoing confusion. Oct(suppl):13-15
My sister had a venous thromboembolism. Will I? Jul:36-38
Overview and implications of the Women’s Health Initiative. Jan(CME suppl):4-7
Preventing heart disease in women: role and limitations of life-style change. Aug:14-18
Results and implications of the Women’s Health Initiative trial of estrogen plus progestin. Oct(suppl):3-6
The role of expanded cholesterol testing. Oct:36-40
Using available data to select a hormone therapy. Oct(suppl):10-12

back to top

Continuing medical education (CME)
Asthma in women: the hormonal link. Sep:34-41 [test 55-56]
Bacterial vaginosis: diagnosis and therapy. Aug:21-26 [test 43-44]
Bladder conditions in women [test]. Jun(CME suppl):31-32
Clinical and social implications of genital herpes [test]. Apr(CME suppl):27-28
Colorectal cancer screening [test]. Nov(CME suppl):15-16
Diabetes in women. Feb:16-21 [test 73-74]
Diagnostic evaluation of chronic pelvic pain of bladder origin. Jul(CME suppl):1-7 [test 8]
Extended cycle contraception: a shift in paradigm [test]. Dec(CME suppl):27-28
Fertility-sparing treatment options for women with symptomatic fibroids. Nov:21-26 [test 63-64]
Irritable bowel syndrome. Jan:16-22 [test 61-62]
Meigs syndrome: does it relate to the etiology of benign ascites? Mar:15-19 [test 69-70]
Migraine headaches, pt 1: presentation and diagnosis. May:32-39 [test 57-58]
Migraine headaches, pt 2: treatment options. Jun:22-29 [test 51-52]
Migraine headaches, pt 3: hormonal factors. Jul:24-27 [test 51-52]
Practice parameters for bacterial vaginosis [test]. Feb:15-16
Pregnancy in the lupus patient. Apr:12-15 [test 63-64]
Biologic agents in the treatment of rheumatoid arthritis. Dec:27-31 [test 61-62]
The role of expanded cholesterol testing. Oct:36-40 [test 55-56]
The Women’s Health Initiative: where do we go from here? [test] Jan:23-24

back to top

Contraception and contraceptives
Condom use: a women’s issue. Feb:53-54
Contraception in the lupus patient. Apr:51-52,61
Contraception plus therapy. S41:10-12
Contraception update, pt 1. Nov:42-44,47-51
Contraception update, pt 2. Dec:32-34,39-40
Current trends in contraception—extended-cycle options. Dec(CME suppl):18-23
Emergency contraception: what’s new. Dec:58-59
Extended cycle oral contraception—clinical experiences. Dec(CME suppl):10-12,17
Extended cycle contraception: a shift in paradigm - introduction. Dec(CME suppl):3-4
The faculty speaks: questions & answers. Dec(CME suppl):24-26
From perimenopause through postmenopause: managing the transition. Jun(suppl):4-8
The health care provider’s blueprint for success. Sep(suppl):1-4
A healthy approach to contraception. S41:8-9
Hormonal contraceptives and menstrual changes: strategies for effective counseling. Sep:12-23
Just say no every now and then. Jun:45-47
A new way to manage menstruation. S41:5-7
Oral contraceptives: choose when—and whether—to bleed. Oct:41-42
Progestins in oral contraceptives: a comparative review. Feb:43-50
Researching your contraceptive options: the IUS. S41:3-4
The sociology and physiology of menstruation. Dec(CME suppl):5-9
What’s new in contraception. Mar:20-28

back to top

Cosmetic procedures
History and use of the 21st centuries’ fountain of youth. Feb:62-65
Looking happier with botox. S38:16
Nonsurgical facial rejuvenation. Nov:41-43

back to top

Dermatologic disorders
Dermatoses of pregnancy. May:24-31

back to top

Diabetes
Diabetes in women. Feb:16-21
Diabetes: treatment considerations in older women. Jun(suppl):21-25
Insulin delivery system options in diabetes: novel approaches to an old disease. Jul:31-35
Targeting glycemic control. Nov:14,16,19-20

back to top

Diet
Preventing heart disease in women: role and limitations of life-style change. Aug:14-18

back to top

Editorials
Are our patients safe? Dec:11-12
Chronic daily headaches: focus on prevention. Jul:12-13
Congratulations Vivian and is the media tinged? Apr:8-11
Defining and achieving career goals in medicine. Jun:10
Evidence-based medicine or magical thinking. Jun(suppl):3
Evidence is in the eye of the beholder. Jan:12
Female sexual dysfunction: a topic for continuing medical education. Aug:12-13
HIV… the insidious disease. Sep:10
Moving toward the future. Nov:11-12
The real primary care. Mar:12
Refocusing the endoscope. Oct:10
Residents and decreased duty hours. Feb:8
The suit and division chief. May:22-23

back to top

Exercise
Prenatal yoga: what you need to know. Feb:66-70
Preventing heart disease in women: role and limitations of life-style change. Aug:14-18

back to top

Gastrointestinal disorders
Irritable bowel syndrome. Jan:16-22

back to top

Genetics
Clinical data on stool-based colorectal cancer screening test. Nov(CME suppl):6-8
Establishing a colorectal cancer screening program. Nov(CME suppl):9-12
The critical role of the primary care physician, ob/gyn, and the nurse practitioner in
colorectal cancer screening. Nov(CME suppl):1-2
Genetic testing for Alzheimer disease. May:40-43
The importance of colorectal cancer screening. Nov(CME suppl):3-6
Meigs syndrome: does it relate to the etiology of benign ascites? Mar:15-19
My sister had a venous thromboembolism. Will I? Jul:36-38
Prenatal screening for adult onset conditions. Mar:53-54
Update on prenatal genetic screening. Sep:45-50

back to top

Gynecologic disorders
Bacterial vaginosis: diagnosis and therapy. Aug:21-26
Comparator trials. Jun(CME suppl):9-14
Counseling in the context of vaginal infections. Feb(CME suppl):12-14
Diagnosis and treatment of vaginal infections. Feb(CME suppl):8-11
Diagnostic evaluation of chronic pelvic pain of bladder origin. Jul(CME suppl):1
Framework for understanding overactive bladder, interstitial cystitis, urinary tract infection. Jun(CME suppl):5-8
Images in women’s health. Jan:51-52; Feb:71-72; Mar:65-66; Apr:59-60; Jun:41-42; Jul:49-50; Aug:41-42; Sep:53-54; Dec:53-54,57
Incidence, prevalence, and quality of life. Jun(CME suppl):3-4
Meigs syndrome: does it relate to the etiology of benign ascites? Mar:15-19
A new approach to evaluating and treating pelvic floor muscle atrophy in women. Feb:32-38
Providing individualized postmenopausal care: navigation through a diverse
population. Jan(CME suppl):8-15
Vaginal infections: meeting patients’ needs. Feb(CME suppl):2

back to top

Headache
Chronic daily headaches: focus on prevention. Jul:12-13
Exogenous hormones and migraine risk management in perimenopausal patients. Apr:55-58
Migraine headaches, pt 1: presentation and diagnosis. May:32-39
Migraine headaches, pt 2: treatment options. Jun:22-29
Migraine headaches, pt 3: hormonal factors. Jul:24-27
Neurologic management of headache in women. Apr:41-48

back to top

Hormones and hormone therapy
A new look at progestogens. Oct(suppl):7-9
Asthma in women: the hormonal link. Sep:34-41
Considerations for patient evaluation by menopausal stage and HT use [chart]. Jan(CME suppl):22
Contraception in the lupus patient. Apr:51-52,61
Current trends in contraception—extended-cycle options. Dec(CME suppl):18-23
Emergency contraception: what’s new. Dec:58-59
Estrogen and cognition. Jan(CME suppl):16-20
Exogenous hormones and migraine risk management in perimenopausal patients. Apr:55-58
Extended cycle contraception: a shift in paradigm. Dec(CME suppl):3-28
Extended cycle oral contraception—clinical experiences. Dec(CME suppl):10-12,17
Extended cycle contraception: a shift in paradigm - introduction. Dec(CME suppl):3-4
The faculty speaks: questions & answers. Jan(CME suppl):21
The faculty speaks: questions & answers. Dec(CME suppl):24-26
From perimenopause through postmenopause: managing the transition. Jun(suppl):4-8
Hormonal contraceptives and menstrual changes: strategies for effective counseling. Sep:12-23
Hormone replacement therapy to prevent cardiovascular disease. Jun(suppl):15-20
Implications of the Women’s Health Initiative – introduction. Oct(suppl):1-2
Individualizing postmenopausal hormone therapy: a focus on symptom management. May:44-51,56
Insulin delivery system options in diabetes: novel approaches to an old disease. Jul:31-35
Managing the patient amid ongoing confusion. Oct(suppl):13-15
Migraine headaches, pt 3: hormonal factors. Jul:24-27
Neurologic management of headache in women. Apr:41-48
Norethindrone acetate versus medroxyprogesterone acetate: a review of current evidence. Aug:34-38
Overview and implications of the Women’s Health Initiative. Jan(CME suppl):4-7
Progestins in oral contraceptives: a comparative review. Feb:43-50
Providing individualized postmenopausal care: navigation through a diverse population. Jan(CME suppl):8-15
Results and implications of the Women’s Health Initiative trial of estrogen plus progestin. Oct(suppl):3-6
The sociology and physiology of menstruation. Dec(CME suppl):5-9
Using available data to select a hormone therapy. Oct(suppl):10-12
What’s new in contraception. Mar:20-28

back to top

Infections
Bacterial vaginosis: diagnosis and therapy. Aug:21-26
Counseling in the context of vaginal infections. Feb(CME suppl):12-14
Diagnosis and treatment of vaginal infections. Feb(CME suppl):8-11
Diagnosis: infections and the nature of the disease. Apr(CME suppl):3-7
Forensic examination of the female sexual assault victim, pt 1: basic procedure. Apr:25-32
Forensic examination of the female sexual assault victim, pt 2: special techniques and circumstances. Jun:30-37
HIV… the insidious disease. Sep:10
Genital herpes: goals of antiviral therapy. Apr(CME suppl):23-26
Genital herpes: impact on sexual health. Apr(CME suppl):8-9
Genital herpes resources. Apr(CME suppl):29
Genital herpes [treatment algorithm]. Apr(CME suppl):14-15
New strategies for preventing neonatal herpes. Apr(CME suppl):19-21
Psychosocial issues in the management of genital herpes. Apr(CME suppl):10-18
Vaginal infections: meeting patients’ needs. Feb(CME suppl):2

back to top

Laparoscopy
Images in women’s health. Apr:59-60; Aug:41-42; Sep:53-54
Treatment of obesity in the female patient: the role of laparoscopic adjustable gastric banding. Aug:27-33

back to top

Menopause
Alzheimer’s disease and dementia: new insights. Jan:58-60
A new look at progestogens. Oct(suppl):7-9
Asthma in women: the hormonal link. Sep:34-41
Considerations for patient evaluation by menopausal stage and HT use [chart]. Jan(CME suppl):22
Diabetes: treatment considerations in older women. Jun(suppl):21-25
Estrogen and cognition. Jan(CME suppl):16-20
Evidence-based medicine or magical thinking. Jun(suppl):3
Exogenous hormones and migraine risk management in perimenopausal patients. Apr:55-58
The faculty speaks: questions & answers. Jan(CME suppl):21
From perimenopause through postmenopause: managing the transition. Jun(suppl):4-8
Individualizing postmenopausal hormone therapy: a focus on symptom management. May:44-51,56
Implications of the Women’s Health Initiative – introduction. Oct(suppl):1-2
Managing the patient amid ongoing confusion. Oct(suppl):13-15
Norethindrone acetate versus medroxyprogesterone acetate: a review of current evidence. Aug:34-38
Overview and implications of the Women’s Health Initiative. Jan(CME suppl):4-7
Providing individualized postmenopausal care: navigation through a diverse population. Jan(CME suppl):8-15
Results and implications of the Women’s Health Initiative trial of estrogen plus progestin. Oct(suppl):3-6
Treating hot flashes: Options to Estrogen. Nov:52-54
Using available data to select a hormone therapy. Oct(suppl):10-12

back to top

Menstruation
Contraception plus therapy. S41:10-12
Hormonal contraceptives and menstrual changes: strategies for effective counseling. Sep:12-23
A new way to manage menstruation. S41:5-7
Oral contraceptives: choose when—and whether—to bleed. Oct:41-42

back to top

Neurologic disorders
Alzheimer’s disease and dementia: new insights. Jan:58-60
Estrogen and cognition. Jan(CME suppl):16-20
Genetic testing for Alzheimer disease. May:40-43

back to top

Obesity
Preventing heart disease in women: role and limitations of life-style change. Aug:14-18
Treatment of obesity in the female patient: the role of laparoscopic adjustable gastric banding. Aug:27-33

back to top

Obstetrics and gynecology
The health care provider’s blueprint for success. Sep(suppl):1-4
Progesterone for the prevention of preterm delivery: prime time or pretender? Dec:23,26-28
Progesterone for the prevention of preterm delivery: ready for prime time? Dec:22,24-25,28
Residency conundrums: approaches to six vexing scenarios. Oct:12-20
Tilting at windmills: selected term vaginal breech delivery should not be abandoned. Jan:29,32-37
Twin and triplet births: facts, figures, and costs. Jun:11-16
Vaginal breech delivery in term singletons can no longer be justified. Jan:28,30-31

back to top

Osteoporosis
Providing individualized postmenopausal care: navigation through a diverse population. Jan(CME suppl):8-15
An update on osteoporosis. Jun(suppl):9-14

back to top

Pain
Chronic pain management and your medical license: 10 things you should know. Jan:38-41
Diagnostic evaluation of chronic pelvic pain of bladder origin. Jul(CME suppl):1-7
The evaluation and treatment of interstitial cystitis. Jun(CME suppl):19-26
Framework for understanding overactive bladder, interstitial cystitis, urinary tract infection. Jun(CME suppl):5-8
Heat therapy: the next hot topic. Mar:30-39
Incidence, prevalence, and quality of life. Jun(CME suppl):3-4

back to top

Patient education
Bladder condition resources. Jun(CME suppl):33
Bladder control problems [patient handout]. Jun(CME suppl):16
Bladder evaluation diary [patient handout]. Jun(CME suppl):17
Colorectal cancer screening can save your life [patient handout]. Nov(CME suppl):13-14
Commonly asked questions about extended-cycle oral contraception. Dec(CME suppl):15-16
Counseling in the context of vaginal infections. Feb(CME suppl):12-14
Genital herpes resources. Apr(CME suppl):29
The health care provider’s blueprint for success. Sep(suppl):1-4
Pelvic pain and urgency/frequency patient symptom scale. Jun(CME suppl):18
Psychosocial issues in the management of genital herpes. Apr(CME suppl):10-18
What you should know about…

Alzheimer’s disease. Jan:63-64
Anxiety. Mar:71-72
Asthma. Sep:57-58
Breast cancer screening. Oct:59-60
Cholesterol. Jul:53-54
Contraceptive surgery. Aug:47-48
Extended-cycle oral contraception. Dec(CME suppl):13-14
Genital herpes. Apr(CME suppl):13,16
Heart disease in women. Jun:53-54
Lupus. Feb:75-76
Migraine headaches. Apr:65-66
Osteoporosis. May:59-60
Rheumatoid arthritis. Dec:63-64
Type 2 diabetes. Nov:65-66

back to top

Pharmacotherapy
The 2002 sexually transmitted diseases treatment guidelines. Feb(CME suppl):3-7
Biologic agents in the treatment of rheumatoid arthritis. Dec:27-31
Chronic pain management and your medical license: 10 things you should know. Jan:38-41
Comparator trials. Jun(CME suppl):9-14
Diabetes: treatment considerations in older women. Jun(suppl):21-25
Diagnosis and treatment of vaginal infections. Feb(CME suppl):8-11
The evaluation and treatment of interstitial cystitis. Jun(CME suppl):19-26
Genital herpes: goals of antiviral therapy. Apr(CME suppl):23-26
Genital herpes [treatment algorithm]. Apr(CME suppl):14-15
Identifying and treating depression in women: beyond the obvious. Mar:43-52
Individualizing postmenopausal hormone therapy: a focus on symptom management. May:44-51,56
Insulin delivery system options in diabetes: novel approaches to an old disease. Jul:31-35
Migraine headaches, pt 2: treatment options. Jun:22-29
The psychopharmacologic basis of energy and fatigue. Sep:24-32,50
Systemic lupus erythematosus: pathogenesis, diagnosis, and treatment. Feb:25-31
An update on osteoporosis. Jun(suppl):9-14

back to top

Pregnancy
Abdominal pregnancy revealed following vaginal hysterectomy. May:55-56
Asthma in women: the hormonal link. Sep:34-41
Dermatoses of pregnancy. May:24-31
From perimenopause through postmenopause: managing the transition. Jun(suppl):4-8
The health care provider’s blueprint for success. Sep(suppl):1-4
Migraine headaches, pt 3: hormonal factors. Jul:24-27
Neurologic management of headache in women. Apr:41-48
New challenges in cesarean delivery. Jul:14-21,50
New strategies for preventing neonatal herpes. Apr(CME suppl):19-21
Pregnancy in the lupus patient. Apr:12-15
Prenatal screening for adult onset conditions. Mar:53-54
Prenatal yoga: what you need to know. Feb:66-70
Progesterone for the prevention of preterm delivery: prime time or pretender? Dec:23,26-28
Progesterone for the prevention of preterm delivery: ready for prime time? Dec:22,24-25,28
Tilting at windmills: selected term vaginal breech delivery should not be abandoned. Jan:29, 32-37
Tobacco and ethanol use in pregnancy: implications for obstetric and anesthetic management. Apr:16-22
Twin and triplet births: facts, figures, and costs. Jun:11-16
Update on prenatal genetic screening. Sep:45-50
Vaginal breech delivery in term singletons can no longer be justified. Jan:28, 30-31

back to top

Prenatal screening
Prenatal screening for adult onset conditions. Mar:53-54
Tobacco and ethanol use in pregnancy: implications for obstetric and anesthetic management. Apr:16-22
Update on prenatal genetic screening. Sep:45-50

back to top

Preventive medicine
Chronic daily headaches: focus on prevention. Jul:12-13
Clinical data on stool-based colorectal cancer screening test. Nov(CME suppl):6-8
The critical role of the primary care physician, ob/gyn, and the nurse practitioner in colorectal cancer screening. Nov(CME suppl):1-2
Establishing a colorectal cancer screening program. Nov(CME suppl):9-12
The importance of colorectal cancer screening. Nov(CME suppl):3-6
The importance of screening: the case for colorectal cancer. Oct:50-53
New strategies for preventing neonatal herpes. Apr(CME suppl):19-21
Prevention of perioperative neuropathies. Oct:23-35
An update on osteoporosis. Jun(suppl):9-14

back to top

Psychiatric disorders
Coping with systemic lupus erythematosus. Jun:38-40
Identifying and treating depression in women: beyond the obvious. Mar:43-52
Irritable bowel syndrome. Jan:16-22
The psychopharmacologic basis of energy and fatigue. Sep:24-32,50
Psychosocial issues in the management of genital herpes. Apr(CME suppl):10-18

back to top

Regulatory issues
Are our patients safe? Dec:11-12
Chronic pain management and your medical license: 10 things you should know. Jan:38-41
Congratulations Vivian and is the media tinged? Apr:8-11
The suit and division chief. May:22-23

back to top

Resources
Bladder condition resources. Jun(CME suppl):33
Genital herpes resources. Apr(CME suppl):29

back to top

Screening
Clinical data on stool-based colorectal cancer screening test. Nov(CME suppl):6-8
Computerized analysis of breast images. Oct:45-49
Considerations for patient evaluation by menopausal stage and HT use [chart]. Jan(CME suppl):22
The critical role of the primary care physician, ob/gyn, and the nurse practitioner in colorectal cancer screening. Nov(CME suppl):1-2
Establishing a colorectal cancer screening program. Nov(CME suppl):9-12
The importance of colorectal cancer screening. Nov(CME suppl):3-6
The importance of screening: the case for colorectal cancer. Oct:50-53
Potassium sensitivity test. Jun(CME suppl):27-30
Providing individualized postmenopausal care: navigation through a diverse population. Jan(CME suppl):8-15
The role of expanded cholesterol testing. Oct:36-40

back to top

Sexual assault
Forensic examination of the female sexual assault victim, pt 1: basic procedure. Apr:25-32
Forensic examination of the female sexual assault victim, pt 2: special techniques and circumstances. Jun:30-37

back to top

Sexuality
Chronic illnesses and disabilities affecting women’s sexuality. Jan:45-50
Discussing sex with patients. May:52
Female sexual dysfunction: a topic for continuing medical education. Aug:12-13
Is my sex life normal? Sep:51-52
Quality of life and the meaning of sexuality. Jul:44-45
Talking about sex. Feb:55-56

back to top

Sexually transmitted diseases (STDs)
The 2002 sexually transmitted diseases treatment guidelines. Feb(CME suppl):3-7
Condom use: a women’s issue. Feb:53-54
Diagnosis and treatment of vaginal infections. Feb(CME suppl):8-11
Forensic examination of the female sexual assault victim, pt 1: basic procedure. Apr:25-32
Forensic examination of the female sexual assault victim, pt 2: special techniques and circumstances. Jun:30-37
Genital herpes: goals of antiviral therapy. Apr(CME suppl):23-26
Genital herpes: impact on sexual health. Apr(CME suppl):8-9
Genital herpes resources. Apr(CME suppl):29
Genital herpes [treatment algorithm]. Apr(CME suppl):14-15
New strategies for preventing neonatal herpes. Apr(CME suppl):19-21
Psychosocial issues in the management of genital herpes. Apr(CME suppl):10-18
Some common sexually transmitted diseases: an update for women’s health care practitioners. Nov:31-31,34,39-41

back to top

Substance abuse
Tobacco and ethanol use in pregnancy: implications for obstetric and anesthetic
management. Apr:16-22

back to top

Surgery
Abdominal pregnancy revealed following vaginal hysterectomy. May:55-56
Abdominoplasty. Jul:46-48
New challenges in cesarean delivery. Jul:14-21,50
Prevention of perioperative neuropathies. Oct:23-35
Reduction mammaplasty. Mar:56-64
Refocusing the endoscope. Oct:10

back to top

Ultrasonography
Computerized analysis of breast images. Oct:45-49
Images in women’s health. Jan:51-52; Mar:65-66; Apr:59-60; Jun:41-42; Jul:49-50; Sep:53-54
Images in women’s health. Dec:53-54,57

back to top